Provenance
Written by SPS and the College of Sexual and Reproductive Health (CoSRH), with the support of specialist stakeholders working within clinical practice, for use within reproductive services.
August 2025 – note the Faculty of Sexual and Reproductive Healthcare (FSRH) has now changed its name to the College of Sexual and Reproductive Healthcare (CoSRH). Some web pages and CoSRH documents will continue to display the FSRH name; where you see FSRH, this refers to CoSRH. All weblinks are still active. The wording in the PGD/protocol templates will be updated at their next review.
PGD template attachment
The template PGD is attached below to download and use in conjunction with our implementation advice.
More reproductive health PGD templates
- Copper Intrauterine Device (Cu-IUD)
- Lidocaine 10mg/ml spray for IUC insertion or removal
- Lidocaine plus prilocaine cream for IUC insertion or removal
- Progestogen-Only Intra-Uterine Device (LNG-IUD) for contraception
- Medroxyprogesterone acetate (DMPA) IM injection for contraception
- Progestogen only pill (POP) for contraception
- Combined hormonal contraceptive transdermal patch
- Combined oral hormonal contraceptive (COC) in reproductive health
- Combined hormonal contraceptive vaginal ring
- Ulipristal acetate 30mg tablets for emergency contraception
- Levonorgestrel 1500 microgram tablets for emergency contraception
- Etonogestrel (e.g. Nexplanon®) implant for contraception
- Lidocaine injection for subdermal etonogestrel in contraception
All PGD templates
National PGD templates
National PGD templates are developed with experts for clinical specialties. They reduce duplication and variation, and improve consistency of care.
Update history
- Information added regarding name change of FSRH to CoSRH
- Version 2.3 PGD template added. Updated contraindications and cautions in line with SmPC changes.
- Updated PGD template published - statement added regarding a suggested link between the prolonged use of medroxyprogesterone acetate and a small increased risk of intracranial meningioma in line with FSRH statement. Added exclusion of meningioma as per SPC.
- Version 2.1 published - minor changes to align with updated FSRH guidance
- Expiring template removed.
- Title, URL and summary amended.
- Version 2.0 PGD template added
- Published